Others, he said, are "backing off given the cost." "I wouldn't really be directional one way or the other on whether or not we're seeing more or less coverage on the weight loss side as we look forward," Thompson said
In the highest-dose group, about 60 percent of participants lost at least 10 percent of their body weight, while 40 percent lost 15 percent or more
For weight management, the FDA-approved options are Wegovy (semaglutide), Zepbound (tirzepatide), and Foundayo (orforglipron)
I had a patient who developed perioral paresthesias after significant weight loss on semaglutide
What are the known safety concerns with GHK-Cu
Carnitine is a pharmacological allosteric chaperone of the human lysosomal -glucosidase